ABSTRACT Background: Measures of blood pressure variation have been associated with cardiovascular disease and related outcomes. The regular consumption of black tea can lower blood pressure, but its effects on blood pressure variation have yet to be investigated. Objective: We aimed to assess the effects of black tea consumption on the rate of ambulatory blood pressure variation. Design: Men and women (n = 111) with systolic blood pressure between 115 and 150 mm Hg at screening were recruited in a randomized, controlled, double-blind, 6-mo parallel-designed trial designed primarily to assess effects on blood pressure. Participants consumed 3 cups/d of either powdered black tea solids (tea) or a flavonoid-free caffeine-matched beverage (control). The 24-h ambulatory blood pressure level and rate of measurement-to-measurement blood pressure variation were assessed at baseline, day 1, and 3 and 6 mo. Results: Across the 3 time points, tea, compared with the control, resulted in lower rates of systolic (P = 0.0045) and diastolic (P = 0.016) blood pressure variation by w10% during nighttime (2200-0600). These effects, which were immediate at day 1 and sustained over 6 mo, were independent of the level of blood pressure and heart rate. The rate of blood pressure variation was not significantly altered during daytime (0800-2000). Conclusions: These findings indicate that a component of black tea solids, other than caffeine, can influence the rate of blood pressure variation during nighttime. Thus, small dietary changes have the potential to significantly influence the rate of blood pressure variation. This trial was registered at the Australian New Zealand Clinical Trials Registry as ACTR12607000543482.
INTRODUCTION
High blood pressure (BP) is a leading risk factor for cardiovascular and total mortality (1) . In many countries, hypertension accounts for approximately one-half of risk of vascular events (2) . The level of BP is the main indicator of individual risk, and a commonly held view is that this level accounts for all of the BP-related risk of vascular events (3) . However, other measures derived from the assessment of BP, such as its variability and rate of variation, may also contribute to risk (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) .
Both the BP level and its variation may be important determinants of hypertensive end-organ damage (3, 4) . There is increasing evidence that BP variability, measured within a 24-h period and visit to visit, is an independent risk factor for cardiovascular disease (5, (9) (10) (11) (12) . In addition, a lower rate of measurement-tomeasurement BP variation has been associated with outcomes related to better cardiovascular health (6) (7) (8) .
There is mounting evidence that black tea and its flavonoids improve BP and cardiovascular health (13) (14) (15) . Higher tea and flavonoid intakes have been linked to better cardiovascular health (16) and have been consistently associated with reduced risk of stroke (17) , which is the outcome that is most strongly related to BP (18) . The regular consumption of black tea can lower BP (14, 15) . Indirect evidence also indicated that tea may reduce BP variation by blunting transient BP changes after a meal (19) (20) (21) .
Population changes to diet and lifestyle are the primary means of combating hypertension and cardiovascular disease (22) . There are few data that have related diet to measures derived from the assessment of BP, other than the BP level. The current trial was designed primarily to assess effects of drinking black tea on BP levels. We showed that regular black tea consumption can lower BP (15) . BP data collected also afforded the opportunity to explore the novel hypothesis that black tea can influence the rate of BP variation. Therefore, the primary objective of this analysis was to assess the effects of drinking black tea on the rate of BP variation.
SUBJECTS AND METHODS

Study subjects
Volunteers were recruited from the general population of Perth, Australia, by using print media advertisements. The primary inclusion criterion was a 4-h daytime ambulatory systolic BP between 115 and 150 mm Hg and ambulatory diastolic BP ,100 mm Hg. This criterion was used because risk of cardiovascular mortality begins to increase from a systolic BP as low as 115 mm Hg (23) , and a large proportion of the general population have systolic BP within this range, which made the results of this study applicable to individuals at higher risk of developing hypertension. Participants were tea drinkers, were aged 35-75 y, had BMI (in kg/m 2 ) of 19-35, were nondiabetic, had not taken nutritional supplements or antibiotics from 4 wk before beginning the trial, and had no major illness. See Table S1 under "Supplemental data" in the online issue for a complete list of all inclusion and exclusion criteria. The trial was approved by the University of Western Australia Ethics Committee and registered at the Australian New Zealand Clinical trials Registry as ACTR12607000543482. Procedures followed were in accordance with institutional guidelines.
Study design
A randomized, controlled, double-blind, 6-mo parallel-designed intervention study was performed. The 6-mo intervention was preceded by a 4-wk run-in period during which participants consumed 3 cups of regular leaf tea each day prepared in the usual manner. During the fourth week of the run-in period, participants attended the School of Medicine and Pharmacology research unit located at Royal Perth Hospital where all baseline measurements were performed. During the 6-mo intervention period, participants consumed 3 cups/d of either powdered black tea solids, which supplied 429 mg total polyphenols (primarily flavonoids)/d and 96 mg caffeine (tea)/d or a flavor-matched, flavonoid-free, and caffeine-matched placebo (control) ( Table 1) . Participants were advised to consume tea or control products at the time that they would normally consume tea. Ambulatory BP measurements were performed again at day 1 and 3 and 6 mo. Volunteers continued to consume the assigned beverage during each ambulatory BPmonitoring period.
Participants were enrolled in the study by a clinical trials coordinator. Before the 4-wk run-in period, volunteers were randomly assigned (1:1) by using computer-generated random numbers. Randomization codes were generated by a statistician who worked independent of study investigators with Unilever Research and Development. Randomization codes consisted of a 4-digit number linked to the study products (ie, either the control or active tea). Study products were sachets labeled with 10 different randomly generated numbers of 4 digits (5 numbers were linked to the placebo, and 5 numbers were linked to active tea). This labeling prevented volunteers from finding out what product they were consuming by talking to each other. This method also maintained the blinding of researchers who performed measurements during the study. A total of 120 envelopes numbered 1-120, each of which contained one 4-digit number (60 numbers were linked to the control, and 60 numbers were linked to active tea), were produced independent of study researchers. The envelopes were provided to the lead investigator (JMH), who was not involved directly in the performance of any outcome measurements. Envelopes were opened in consecutive order by the lead investigator as each participant entered into the study. Participants and study investigators remained blinded to treatment allocation.
After random assignment, participants were required to follow a low-flavonoid diet throughout the trial. Apart from the prescribed tea intake, participants did not consume any additional tea, they did not consume dark chocolate or red wine, the intake of fruit juices was limited to ,4 glasses/wk, and coffee intake was limited to ,1 cup/d on average (,7 cups/wk). A dietitian monitored each participant's progress every 4 wk to ensure compliance.
Test products were supplied at 4-wk intervals as dry powders in sachets (100 sachets for each 4-wk period). Two test products were matched for color and flavor, and to improve blinding, participants were only ever exposed to one of the 2 products. Participants were instructed to add the contents of a sachet to w200 mL boiled hot water and stir the solution until the powder completely dissolved. The addition of sugar, milk, cream, or other additives was not allowed, and the product was consumed while still hot. Volunteers consumed 3 sachets of the test product each day. Volunteers returned excess sachets and empty sachets during the 4-wk visits. Returned sachets were used to verify compliance.
BP
Screening BP was assessed as 4-h daytime ambulatory BP with BP and heart rate measured every 20 min. During the study, BP was assessed as 24-h ambulatory BP with BP and heart rate measured every 20 min during the daytime and every 30 min at nighttime (15, 24) . These measurements were performed at baseline, day 1, and 3 and 6 mo. Ambulatory BP was assessed by a trained researcher who fitted a Spacelabs monitor (Spacelabs Medical Inc) and explained its use to the participants. The monitor was fitted to the nondominant arm w2.5 cm above the antecubital fossa. Participants were instructed to continue their usual daily activities and to avoid any vigorous exercise. Measurements that showed an error code or those with a pulse pressure ,20 mm Hg were excluded from the analysis. BP traces were complete if .80% of recordings were valid.
The within-visit rate of variation and variability of systolic and diastolic BP and heart rate were calculated for daytime (0800-2000) and nighttime (2200-0600) periods from 24-h ambulatory BP traces. The 24-h rate of BP variation was not considered for analysis because BPs usually dip overnight with sleeping and rise rapidly in the morning on waking. Periods with the steepest fall (2000-2200) and rise (0600-0800) in BP were excluded from the analysis because a greater difference, which is associated with lower risk of cardiovascular disease, contributes to increased rate of variation. It was not anticipated before the analysis that there would be any difference in the effect between daytime and nighttime. Measurement of within-visit rate of measurement-to-measurement BP and heart-rate variation involved the calculation of the slope for the change in systolic BP, diastolic BP, and heart rate between each reading over time. The slope for each data point in the recording was calculated and allocated to a particular hour. Absolute values of slopes of each hour as well as the preceding and subsequent hours (median 6 SD number of values over each 3-h period: 8 6 1.6) were averaged to give one value. This value provides a 3-h moving average over the 24 h and indicated short-term variation. This process was a modification of the method described in detail by Zakopoulos et al (6) . We also assessed BP variability. These measures provided only a single summary measure rather than continuous hourly measurement over 24 h as is the case with the rate of BP variation. For this reason, the power to detect any effect of tea was reduced for these measures. Within-visit ambulatory BP variability was measured as the SD of BP measurements during the daytime (0800-2000) and nighttime (2200-0600) periods as well as over 24 h as the weighted 24-h SD according Bilo et al (25) . The visitto-visit BP variability was assessed as the SD of the mean 24-h BP measurements performed at day 1 and 3 and 6 mo.
Diet, body weight, and biochemistry
Dietary intake was assessed by using a 3-d weighed food diary completed on 2 weekdays and 1 d of the weekend. Food-intake data were analyzed with FoodWorks Software (Xyris) and were based on the Australian Food Composition Database. Body weight was recorded with participants wearing light clothing and no footwear. Height was measured at baseline by using a wallmounted stadiometer. Fasting lipids and glucose were measured in serum samples, and sodium and potassium excretions were measured in a 24-h urine sample by using routine laboratory methods in the PathWest Laboratory at Royal Perth Hospital. Urinary 4-O-methylgallic acid concentrations were measured by using gas chromatography-mass spectrometry according to a previously described method (26) . The 24-h 4-O-methylgallic acid excretion is a biomarker of black tea intake (27) and black tea-derived flavonoid exposure (28) and can be used to assess compliance in clinical trials (29) .
Statistical analysis
The sample size for this study was based on the primary outcome of 24-h ambulatory systolic BP. We estimated that 100 participants (50 participants/group) would provide .90% power at a = 0.05 to detect a difference of 3 mm Hg in 24-h systolic BP. Results of the primary outcome of the study (ie, BP level) have been published (15) . Ambulatory BP data collected also allowed the assessment of the measurement-to-measurement rate of BP variation. The primary analysis was a modified intent-to-treat analysis. The population was defined as participants who were randomly assigned to the study for which there were complete baseline measurements of ambulatory BP and heart-rate variability (n = 92). The reason for withdrawal or missing data was associated with the assigned treatment of only one participant from the control group who was unable to drink the tea provided. Therefore, missing data for participants who were not included in the final analysis were assumed to be missing at random.
Descriptive statistics are presented as means 6 SDs. Categorical variables were summarized by number in each category. A type-1 error rate of P , 0.05 was the level of significance used for all hypothesis testing. Log transformation was performed on variables that were not normally distributed as assessed by using normal probability plots. At baseline, characteristics of participants in the 2 groups were compared by using the independent-samples t test on transformed data when appropriate and the chi-square test for categorical variables. The independent-samples t test was also used to compare descriptive data, including energy and nutrient intakes and urinary analytes, at baseline and 3 and 6 mo and the visit-to-visit SD of 24-h BP. Pearson's correlation coefficient was used to explore the degree and direction of association between variables at baseline. Baseline, day 1, and 3-and 6-mo values for BP variability and between-group differences are presented as least-squares means and 95% CIs.
Outcomes were analyzed by using mixed models in SAS software (version 9.3; SAS Institute Inc). The PROC MIXED command of the SAS program was used to determine the effect of tea compared with the control. Fixed effects in the model included time (at baseline, day 1, and 3 and 6 mo; modeled as 4 separate binary indicator variables), treatment group (tea and control), hour (for the level of BP and rate of BP variation only), and treatment group 3 time (in which time was again modeled as 4 separate binary indicator variables). The overall effect of treatment was established by using the global treatment group 3 time interaction term. Differences between the tea and control were also assessed and reported individually at days 1 and 3 and 6 mo. To determine whether any effects of treatment on the rate of BP variation were independent of the level of BP, heart rate, and BP variability measured as SDs, observed differences were adjusted for the level of BP, heart rate, and SD, which were considered covariates in separate models.
RESULTS
Descriptive and baseline data
The study was performed between October 2007 and September 2010. Ninety-two participants had complete ambulatory BP and heart rate data available at baseline (Figure 1) . At the completion of the study, participants were asked to identify which group (active tea or control) they believed that they were assigned to. Most participants were unsure. However, 12 participants in the control group correctly identified their group, and 5 participants in the active tea group correctly identified their group. This result was not significantly different (P = 0.11), which indicated that blinding was successful.
In all randomly assigned participants, compliance assessed by using sachet counts was 81 6 36% (control) and 87 6 29% (tea). The 24 h 4-O-methylgallic acid excretion data also indicated excellent compliance (Figure 2 ). There were no significant differences between groups in characteristics at baseline ( Table 2) .
Energy and macronutrient intakes and urinary sodium and potassium excretion were maintained unchanged during the intervention. There were no significant differences between groups at baseline or 3 or 6 mo ( Table 3) . Within-visit systolic BP SD and diastolic BP SD were significantly correlated with the rate of BP variation during the daytime (r = 0.62, P , 0.001 and r = 0.39, P , 0.001, respectively) and nighttime (r = 0.40, P , 0.001 and r = 0.53, P , 0.001, respectively).
Rate of BP variation
Across the 3 time points (overall effect of treatment), tea compared with the control resulted in a significantly lower rate of systolic (P = 0.0045) and diastolic (P = 0.016) BP variation during the nighttime. See Figure S1 under "Supplemental data" in the online issue for a summary of these data. Adjustment for nighttime BP or heart rate did not alter observed effects on rates of systolic and diastolic BP variation during the nighttime. Adjustment for nighttime BP variability measured as SDs marginally attenuated observed effects on nighttime rates of systolic (P = 0.016) and diastolic (P = 0.055) BP variation. An analysis of the differences between groups at days 1 and 3 and 6 mo indicated that the effects of tea relative to the control on the nighttime rate of diastolic BP variation were immediate at day 1 and were sustained at 3 and 6 mo ( Table 4) . Tea, compared with the control, did not significantly influence the rate of systolic (P = 0.75) or diastolic (P = 0.11) BP variation during the daytime across the 3 time points, and individual differences between groups at days 1 and 3 and 6 mo were NS (Table 4) .
There was a diurnal pattern of rates of systolic and diastolic BP variation with the nadir between 0200 and 0400, a rapid increase between 0600 and 0800, and a peak between 0800 and 1100 ( Figure  3) . The pattern and timing of peaks was similar for tea and control groups although the nighttime minimum was lower for tea.
BP variability
For nighttime systolic (P = 0.14) and diastolic (P = 0.18) BP SDs, the overall effect of tea across the 3 time points was not significant. However, significantly lower systolic and diastolic BP SDs at day 1 [21.4 (95% CI: 22.7, 20.0; P = 0.05) and 21.0 (95% CI: 22.0, 20.0; P = 0.04), respectively] and a similar trend at 3 mo [21.2 (95% CI: 22.5, 0.1; P = 0.08) and 20.8 (95% CI: 21.8, 20.1; P = 0.08), respectively] were observed. Effects on daytime systolic and diastolic BP SDs, 24-h systolic and diastolic weighted SDs, and nighttime and daytime heart-rate SDs were not significant (data not presented). Differences in the visit-to-visit BP variability did not reach significance. The visit-to-visit systolic BP variability was 2.71 mm Hg (95% CI: 2.18, 3.24 mm Hg) for tea and 3.71 mm Hg (95% CI: 2.74, 4.67 mm Hg) for the control (P = 0.067). The visit-to-visit diastolic BP variability was 2.09 mm Hg (95% CI: 1.63, 2.55 mm Hg) for tea and 2.51 mm Hg (95% CI: 1.85, 3.17 mm Hg) for the control (P = 0.29).
DISCUSSION
There is accumulating evidence to suggest that measures derived from the assessment of BP, in addition to the BP level, are related to risk of cardiovascular disease (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) . In this study, we have investigated acute and longer-term effects of black tea on rates of BP variation and BP variability. Many dietary and lifestyle factors can lower BP levels, but to our knowledge, the effects of 1 Intent-to-treat population included 92 participants with complete ambulatory blood pressure and heart-rate variability data at baseline. P values are for between-group differences and were analyzed by using the independent-samples t test and the chi-square test for categorical variables.
2 Mean 6 SD (all such values).
3 Geometric mean; 95% CI in parentheses (all such values).
TABLE 3
Mean energy and nutrient intakes and urinary analytes of the participants in the control and tea groups at baseline and 3 and 6 mo 1 There were no significant differences between groups at baseline or 3 or 6 mo; analyzed by using the independentsamples t test.
2 Mean 6 SD (all such values). 3 Median; IQR in parentheses (all such values).
TABLE 4
Rates of systolic blood pressure, diastolic blood pressure, and heart-rate variation according to beverage (active tea or control) at baseline, day 1, and 3 and 6 mo and between-group differences at day 1 and 3 and 6 mo specific dietary and lifestyle changes on rates of BP variation and BP variability are unknown. We showed that the consumption of 3 cups flavonoid-rich black tea/d over 6 mo, compared with a caffeine-matched control beverage, resulted in an immediate and sustained lower rate of BP variation at nighttime. These effects were in addition to benefits on BP levels (15) and were independent of the level of nighttime BP, nighttime heart rate, and nighttime BP variability measured as SDs.
We have adapted a method previously described by Zakopoulos et al (6) to provide continuous hourly measurement of the rate of BP variation. The calculation of hourly measurements of the rate of BP variation over 24 h is a major advantage of this method because it increases the power to detect smaller differences. The rate of BP variation assessed by using this method has been associated with the presence of hypertension, increased carotid atherosclerosis (6), increased left ventricular mass (7) , and impaired renal function in hypertensive patients (8) . A higher rate of BP variation of w16%, if causal, would be associated with w50% higher risk of renal impairment (8) . Therefore, our results were consistent with a potential benefit of tea on cardiovascular disease-related outcomes. However, the clinical significance of our findings remains uncertain. To our knowledge, no studies have assessed the relation between the rate of BP variation and cardiovascular events or death. Such studies are needed to determine whether the measurement of rate of BP variation is an important independent predictor of cardiovascular disease outcomes. The lack of observed effects during the daytime may have been related to mechanisms that are responsible for effects at nighttime that do not operate during the daytime. However, the lack may also have be due to increased variability during daytime that was influenced by additional factors such as activity levels, food (meals), and stress levels that could potentially have masked any differences.
A number of methods are used to assess BP variability (5-10, 30, 31), but most often, it is the SD that is used. We observed significantly lower nighttime systolic and diastolic BP SDs at day 1 and a similar trend at 3 mo. However, the overall effect of tea on the nighttime SD across the 3 time points did not reach significance. Although the visit-to-visit systolic and diastolic BP variability appeared to be substantially lower for tea compared with control groups, differences were not significant. A larger sample size may be needed to detect differences in a single summary measure of within-visit or visit-to-visit BP variability.
A limitation of the SD for use with 24-h ambulatory BP measurement is that it provides only a single summary measurement of variability. Furthermore, the SD does not adequately capture the measurement-to-measurement variability. Highly variable readingto-reading changes can have the same variability as a gradual change over several hours. We showed that rates of BP variation and BP variability (SDs) were significantly correlated, but the effects of tea on the rate of BP variation at nighttime were largely independent of the nighttime SD. These results indicated that the rate of BP variation may be a useful additional measure to that of the SD. Furthermore, the continuous hourly measurement of the rate of BP variation may have advantages over the single summary measurement of variability. However, additional studies are needed in which rates of BP variation and BP variability are assessed in relation to cardiovascular disease outcomes.
Mechanisms responsible for benefits of black tea on BP were not addressed in the current study. However, there is indirect evidence that supports a number of potential mechanisms. Tea consumption can blunt transient BP changes after a meal (19) (20) (21) , which could contribute to reduced BP variation during the daytime. Our data indicated a significant difference between groups in the exposure to black tea flavonoids. There is mounting evidence that black tea flavonoids can improve vascular health (13) via effects on nitric oxide status (32) , endothelial function (33) , and arterial stiffness (14) . Acute and short-term improvements in arterial stiffness may contribute to reduced BP variation. Another possibility is that tea may have a rapid onset and sustained diuretic activity (34) . However, the lack of effect on BP variation during the daytime would indicate that these may not be the primary mechanisms involved. An additional possibility is that tea might improve sleep quality via effects on neurocognitive function or autonomic regulation (35) (36) (37) (38) (39) .
In conclusion, we have shown, for the first time to our knowledge, that the consumption of black tea can lower rates of systolic and diastolic BP variation at nighttime. These effects were immediate and sustained during regular black tea consumption over 6 mo. The results show that simple dietary changes can influence BP variation, and a component of black tea solids, other than caffeine, is responsible. Therefore, these results raise a new hypothesis that warrants additional investigation.
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